ILA 885.0
(-0.17%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | -1.2 Million | -1.27 Million | -1.51 Million | -6.61 Million | 2.83 Billion | 3.47 Billion |
Net Income | -1.82 Million | -2.65 Million | 463.81 Million | -474 Thousand | -1 Billion | -1.9 Billion |
Depreciation & Amortization | - | - | - | - | 1.89 Billion | 2.38 Billion |
Deferred income taxes | - | - | - | - | - | -59 Million |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | -6000.00 | - | 3.13 Million | -33 Million | 660 Million |
Other non-cash items | 625 Thousand | 1.39 Million | -465.32 Million | -9.27 Million | 103 Million | 564 Million |
Investing Cash Flow | 268 Thousand | 74 Thousand | - | 9.66 Million | -2.4 Billion | -2.5 Billion |
Investments in PPE | - | - | - | - | -1.31 Billion | -1.6 Billion |
Acquisitions | - | - | - | - | -1.77 Billion | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 268 Thousand | 74 Thousand | - | 9.66 Million | -21 Million | -901 Million |
Financing Cash Flow | - | - | -703 Thousand | - | -1.59 Billion | -2.2 Billion |
Debt repayment | - | - | -15.42 Million | - | -1.11 Billion | -2.31 Billion |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | 117 Million | 97 Million |
Other Financing Activities | - | - | 14.72 Million | - | -4 Million | 16 Million |
Accounts receivables | - | -6000.00 | - | 1.43 Million | 111 Million | 267 Thousand |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | 8 Million | -5 Million |
Other working capital | - | - | - | 1.7 Million | -153 Million | 665 Million |
Cash at beginning of period | 6.65 Million | 7.84 Million | 10.06 Million | 7 Million | 1.17 Billion | 2.4 Billion |
Cash at end of period | 5.71 Million | 6.65 Million | 7.84 Million | 10.06 Million | 7 Million | 1.17 Billion |
Capital Expenditure | - | - | - | - | -1.31 Billion | -1.6 Billion |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -933 Thousand | -1.19 Million | -2.21 Million | 3.06 Million | -1.16 Billion | -1.23 Billion |
Free Cash Flow | -1.2 Million | -1.27 Million | -1.51 Million | -6.61 Million | 1.51 Billion | 1.86 Billion |
Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -1.82 Million | -359.50 | -359.50 | -553.50 | -553.50 | -2.65 Million |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | 9.50 | 9.50 | -9.50 | -9.50 | -6000.00 |
Other non-cash items | 625 Thousand | 25.50 | 25.50 | 287.00 | 287.00 | 1.39 Million |
Investing Cash Flow | 268 Thousand | 67.00 | 67.00 | 67.00 | 67.00 | 74 Thousand |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 268 Thousand | 67.00 | 67.00 | 67.00 | 67.00 | 74 Thousand |
Financing Cash Flow | - | - | - | - | - | - |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | - | - |
Accounts receivables | - | 9.50 | 9.50 | -9.50 | -9.50 | -6000.00 |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | 6.65 Million | - | - | - | - | 7.84 Million |
Cash at end of period | 5.71 Million | -257.50 | -257.50 | -209.00 | -209.00 | 6.65 Million |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -933 Thousand | -257.50 | -257.50 | -209.00 | -209.00 | -1.19 Million |
Free Cash Flow | -1.2 Million | -324.50 | -324.50 | -276.00 | -276.00 | -1.27 Million |
3648
BETRF
AUROPHARMA
SMLR
4058
TW